Camarda Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,742
| Closed | -$2.52M | – | 97 |
|
|
2024
Q3 | $2.52M | Buy |
+12,742
| New | +$2.52M | 0.94% | 34 |
|
|
2020
Q4 | – | Sell |
-14,099
| Closed | -$1.24M | – | 66 |
|
|
2020
Q3 | $1.24M | Hold |
14,099
| – | – | 1.5% | 17 |
|
|
2020
Q2 | $1.38M | Buy |
+14,099
| New | +$1.38M | 1.94% | 14 |
|
|
2019
Q3 | – | Sell |
-399
| Closed | -$29K | – | 34 |
|
|
2019
Q2 | $29K | Sell |
399
-172
| -30% | -$12.5K | 0.06% | 109 |
|
|
2019
Q1 | $46K | Buy |
571
+138
| +32% | +$11.1K | 0.09% | 81 |
|
|
2018
Q4 | $40K | Sell |
433
-16
| -4% | -$1.48K | 0.05% | 88 |
|
|
2018
Q3 | $42K | Hold |
449
| – | – | 0.05% | 116 |
|
|
2018
Q2 | $42K | Hold |
449
| – | – | 0.04% | 113 |
|
|
2018
Q1 | $42K | Sell |
449
-2,012
| -82% | -$188K | 0.04% | 103 |
|
|
2017
Q4 | $238K | Buy |
2,461
+63
| +3% | +$6.09K | 0.28% | 63 |
|
|
2017
Q3 | $213K | Sell |
2,398
-110
| -4% | -$9.77K | 0.23% | 74 |
|
|
2017
Q2 | $182K | Buy |
2,508
+391
| +18% | +$28.4K | 0.19% | 76 |
|
|
2017
Q1 | $138K | Sell |
2,117
-4,681
| -69% | -$305K | 0.13% | 85 |
|
|
2016
Q4 | $426K | Buy |
6,798
+567
| +9% | +$35.5K | 0.29% | 82 |
|
|
2016
Q3 | $393K | Buy |
6,231
+668
| +12% | +$42.1K | 0.24% | 84 |
|
|
2016
Q2 | $344K | Buy |
5,563
+692
| +14% | +$42.8K | 0.22% | 81 |
|
|
2016
Q1 | $278K | Buy |
+4,871
| New | +$278K | 0.17% | 93 |
|
|
2015
Q3 | – | Sell |
-1,095
| Closed | -$74K | – | 165 |
|
|
2015
Q2 | $74K | Buy |
+1,095
| New | +$74K | 0.04% | 117 |
|
|
2013
Q3 | – | Sell |
-35
| Closed | -$1K | – | 97 |
|
|
2013
Q2 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 260 |
|